Pathophysiologic mechanisms of ventricular remodeling;Mecanismos fisiopatológicos da remodelação ventricular

Revista Portuguesa de Cardiologia

Volumn 23, Issue SUPPL. 2, 2004, Pages

  Gonçalves, Lino M ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Heart failure; Ventricular remodeling

Indexed keywords

NEUROHORMONE;

ENERGY TRANSFER; GENE EXPRESSION; HEALTH CARE QUALITY; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; PATHOPHYSIOLOGY; PATIENT CARE; PREVENTIVE MEDICINE; REVIEW; TREATMENT PLANNING; CELL DEATH; CONGESTIVE HEART FAILURE; FIBROSIS; HEART MUSCLE; HUMAN; PATHOLOGY;

CELL DEATH; FIBROSIS; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIUM; VENTRICULAR REMODELING;

EID: 16544378028     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Roberts CS, Maclean D, Maroko P, Kloner RA. Early and late remodeling of the left ventricle after acute myocardial infarction. Am J Cardiol 1984;54:407-10.
2. Weisman HF, Bush DE, Mannisi JA, Bulkley BH. Global cardiac remodeling after acute myocardial infarction: a study in the rat model. J Am Coll Cardiol 1985;5:1355-62.
3. Hutchins GM, Bulkley BH. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol 1978;41:1127-32.
4. Erlebacher JA, Weiss JL, Eaton LW, Lkallman C, Weisfeldt ML, Bulkley BH. Late effects of acute infarct dilatation on heart size: a two dimensional echocardiographic study. Am J Cardiol 1982;49:1120-6.
5. Weisman HF, Healy B. Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts. Prog Cardiovasc Dis 1987;30:73-110.
6. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988; 319:80-6.
7. Sharpe N, Murphy J, Smith H, Hannan S: Treatment of patients with symptomless left ventricular dysfunction after myocardial infarcfion. Lancet 1988;1:255-9.
8. Jugdutt BI, Tymchak W, Humen D, Gulamhusein S, Hales M. Prolonged nitroglycerin versus captopril therapy on remodeling after transmural myocardial infarction. Circulation 1990;82(suppl III):III-442.
9. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
10. The SOLVD investigators. Effect of enalapril on mortality and development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New Engl J Med 1992;327:685-91.
11. Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbility in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med 1992;327:669-77.
12. Gerdes AM. Remodeling of ventricular myocytes during cardiac hypertrophy and heart failure. J Fla Med Assoc 1992;79:253-5.
13. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724-9.
14. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;31:819-23.
15. Gilbert EM, Olsen SL, Renlund DG, Bristow MR. Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy. Am J Cardiol 1993; 71:23C-29C
16. Iaccarino G, Tomhave ED, Lefkowitz RJ, Koch WJ. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. Circulation 1998;98:1783-9.
17. Rockman HA, Chien KR, Choi DJ, Iaccarino G, Hunter JJ, Ross J Jr, Lefkowitz RJ, Koch WJ. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci USA 1998;95:7000-5.
18. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 1998;101:1326-42.
19. Mann DL, Kent RL, Parsons B, Cooper G 4th. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992;85:790-804.
20. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 1998;98:1329-34.
21. Peterson JT, Li H, Dillon L, Bryant JW. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res 2000;46:307-15.
22. Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, Goldberg AT, Zellner JL, Crumbley AJ. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 2000;102:1944-9.
23. Sievers R, Parmley WW, James T, Wikman-Coffelt J. Energy levels at systole vs. diastole in normal hamster hearts vs. myopathic hamster hearts. Circ Res 1983;53:759-66.